Does EVEROLIMUS Cause Product dose omission issue? 190 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 190 reports of Product dose omission issue have been filed in association with EVEROLIMUS (EVEROLIMUS). This represents 0.5% of all adverse event reports for EVEROLIMUS.
190
Reports of Product dose omission issue with EVEROLIMUS
0.5%
of all EVEROLIMUS reports
11
Deaths
49
Hospitalizations
How Dangerous Is Product dose omission issue From EVEROLIMUS?
Of the 190 reports, 11 (5.8%) resulted in death, 49 (25.8%) required hospitalization, and 3 (1.6%) were considered life-threatening.
Is Product dose omission issue Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for EVEROLIMUS. However, 190 reports have been filed with the FAERS database.
What Other Side Effects Does EVEROLIMUS Cause?
Death (5,090)
Malignant neoplasm progression (3,789)
Diarrhoea (3,061)
Fatigue (2,946)
Stomatitis (2,692)
Nausea (2,079)
Dyspnoea (1,925)
Drug ineffective (1,837)
Pyrexia (1,664)
Decreased appetite (1,633)
What Other Drugs Cause Product dose omission issue?
DUPILUMAB (18,189)
USTEKINUMAB (9,405)
GUSELKUMAB (9,267)
LENALIDOMIDE (8,145)
MEPOLIZUMAB (5,873)
TOFACITINIB (5,646)
VOXELOTOR (5,122)
BELIMUMAB (4,671)
SECUKINUMAB (4,572)
APREMILAST (4,460)
Which EVEROLIMUS Alternatives Have Lower Product dose omission issue Risk?
EVEROLIMUS vs EVOLOCUMAB
EVEROLIMUS vs EXELON
EVEROLIMUS vs EXEMESTANE
EVEROLIMUS vs EXENATIDE
EVEROLIMUS vs EXFORGE